KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Medtronic (MDT) Accumulated Depreciation & Amortization (2016 - 2025)

Medtronic's Accumulated Depreciation & Amortization history spans 13 years, with the latest figure at $8.8 billion for Q2 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 11.08% to $8.8 billion in Q2 2025 year-over-year; TTM through Apr 2025 was $8.8 billion, a 11.08% increase, with the full-year FY2025 number at $8.8 billion, up 11.08% from a year prior.
  • Accumulated Depreciation & Amortization hit $8.8 billion in Q2 2025 for Medtronic, up from $7.9 billion in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for MDT hit a ceiling of $8.8 billion in Q2 2025 and a floor of $668.0 million in Q3 2022.
  • Historically, Accumulated Depreciation & Amortization has averaged $3.8 billion across 5 years, with a median of $2.0 billion in 2021.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: surged 194.3% in 2022 and later dropped 6.73% in 2024.
  • Tracing MDT's Accumulated Depreciation & Amortization over 5 years: stood at $1.3 billion in 2021, then decreased by 0.59% to $1.3 billion in 2022, then surged by 534.28% to $8.5 billion in 2023, then decreased by 6.73% to $7.9 billion in 2024, then increased by 11.08% to $8.8 billion in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for MDT at $8.8 billion in Q2 2025, $7.9 billion in Q2 2024, and $8.5 billion in Q2 2023.